Literature DB >> 31563222

Noncirrhotic Portal Hypertension: Current and Emerging Perspectives.

Rajeev Khanna1, Shiv Kumar Sarin2.   

Abstract

Idiopathic portal hypertension (IPH) and extrahepatic portal venous obstruction (EHPVO) are prototype noncirrhotic causes of portal hypertension (PHT), characterized by normal hepatic venous pressure gradient, variceal bleeds, and moderate to massive splenomegaly with preserved liver synthetic functions. Infections, toxins, and immunologic, prothrombotic and genetic disorders are possible causes in IPH, whereas prothrombotic and local factors around the portal vein lead to EHPVO. Growth failure, portal biliopathy, and minimal hepatic encephalopathy are long-term concerns in EHPVO. Surgical shunts and transjugular intrahepatic portosystemic shunt resolve the complications secondary to PHT. Meso-Rex shunt is now the standard-of-care surgery in children with EHPVO.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Animal models; Biliopathy; Extrahepatic portal venous obstruction; Idiopathic portal hypertension; Parenchymal extinction; Rex shunt

Year:  2019        PMID: 31563222     DOI: 10.1016/j.cld.2019.07.006

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  8 in total

Review 1.  Interventional Management of Portal Hypertension in Cancer Patients.

Authors:  Max Kabolowsky; Lyndsey Nguyen; Brett E Fortune; Ernesto Santos; Sirish Kishore; Juan C Camacho
Journal:  Curr Oncol Rep       Date:  2022-08-12       Impact factor: 5.945

Review 2.  Schistosomiasis Pulmonary Arterial Hypertension.

Authors:  Jean Pierre Sibomana; Aloma Campeche; Roberto J Carvalho-Filho; Ricardo Amorim Correa; Helena Duani; Virginia Pacheco Guimaraes; Joan F Hilton; Biruk Kassa; Rahul Kumar; Michael H Lee; Camila M C Loureiro; Sula Mazimba; Claudia Mickael; Rudolf K F Oliveira; Jaquelina S Ota-Arakaki; Camila Farnese Rezende; Luciana C S Silva; Edford Sinkala; Hanan Yusuf Ahmed; Brian B Graham
Journal:  Front Immunol       Date:  2020-12-10       Impact factor: 7.561

3.  Diagnosis and management of extrahepatic oesophageal variceal bleed in children in a low resourced setting.

Authors:  Taiba J Afaa; Kokou H Amegan-Aho; Elikem Richardson; Bamenla Goka
Journal:  Ghana Med J       Date:  2020-12

4.  Simultaneous partial splenectomy during liver transplantation for advanced cirrhosis patients combined with severe splenomegaly and hypersplenism.

Authors:  Wen-Tao Jiang; Jian Yang; Yan Xie; Qing-Jun Guo; Da-Zhi Tian; Jun-Jie Li; Zhong-Yang Shen
Journal:  World J Gastroenterol       Date:  2021-02-21       Impact factor: 5.742

Review 5.  Technical Aspects and Considerations of Meso-Rex Bypass Following Liver Transplantation With Left Lateral Segment Grafts: Case Report and Review of the Literature.

Authors:  Christina Dalzell; Paola A Vargas; Kyle Soltys; Frank Di Paola; George Mazariegos; Nicolas Goldaracena
Journal:  Front Pediatr       Date:  2022-04-25       Impact factor: 3.418

6.  Inhibition of COX-2 ameliorates murine liver schistosomiasis japonica through splenic cellular immunoregulation.

Authors:  Zhang Qi; Chen Lan; Ji Xiaofang; Tang Juanjuan; Fu Cheng; Huang Ting; Shen Erxia; Li Zi
Journal:  Parasit Vectors       Date:  2022-04-23       Impact factor: 4.047

7.  Noncirrhotic portal hypertension due to peripheral T-cell lymphoma, not otherwise specified: A case report.

Authors:  Miao-Miao Wu; Wen-Jun Fu; Jia Wu; Lin-Lin Zhu; Ting Niu; Rong Yang; Jin Yao; Qiang Lu; Xiao-Yang Liao
Journal:  World J Clin Cases       Date:  2022-09-16       Impact factor: 1.534

8.  Parenchymal Extinction Mimicking Hepatocellular Carcinoma in a Patient with Chronic Hepatitis B-Related Liver Cirrhosis.

Authors:  Min Kyu Kang; Joon Hyuk Choi
Journal:  Diagnostics (Basel)       Date:  2021-06-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.